GE HealthCare Technologies AVS — Cost of Sales decreased by 10.4% to $662.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $598.00M to $662.00M. Over 3 years (FY 2022 to FY 2025), AVS — Cost of Sales shows relatively stable performance with a 2.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A decrease relative to revenue suggests improved manufacturing efficiency or better supply chain management, while an increase may indicate rising input costs.
Includes the direct costs attributable to the production of the goods sold or services provided by the segment. This typ...
Commonly referred to as Cost of Goods Sold (COGS) in standard financial reporting across the healthcare equipment industry.
gehc_segment_avs_cost_of_sales| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $618.00M | $618.00M | $618.00M | $618.00M | $621.25M | $621.25M | $621.25M | $621.25M | $599.00M | $611.00M | $608.00M | $667.00M | $598.00M | $637.00M | $655.00M | $739.00M | $662.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.5% | +0.0% | +0.0% | +0.0% | -3.6% | +2.0% | -0.5% | +9.7% | -10.3% | +6.5% | +2.8% | +12.8% | -10.4% |
| YoY Change | — | — | — | — | +0.5% | +0.5% | +0.5% | +0.5% | -3.6% | -1.6% | -2.1% | +7.4% | -0.2% | +4.3% | +7.7% | +10.8% | +10.7% |